Follow
Martin Lazaro Quintela
Martin Lazaro Quintela
Oncólogo médico
Verified email at sergas.es
Title
Cited by
Cited by
Year
Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience
MCA Manrique, JM Martínez, JG González, FJA Afonso, ML Quintela, ...
Translational lung cancer research 7 (3), 404, 2018
622018
Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non–small cell lung carcinoma: the ROSING study
E Conde, S Hernandez, R Martinez, B Angulo, J De Castro, ...
Journal of Thoracic Oncology 14 (12), 2120-2132, 2019
572019
Molecular basis of hypertension side effects induced by sunitinib
G Aparicio-Gallego, FJ Afonso-Afonso, L León-Mateos, JL Fírvida-Pérez, ...
Anti-Cancer Drugs 22 (1), 1-8, 2011
522011
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish …
B Pérez-Valderrama, JAA Arija, AR Sánchez, AP Marín, PB García, ...
Annals of Oncology 27 (4), 706-711, 2016
422016
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study
J Ruiz-Bañobre, A Molina-Díaz, O Fernández-Calvo, N Fernández-Núñez, ...
ESMO open 6 (2), 100090, 2021
352021
Recent advances in genitourinary tumors: a review focused on biology and systemic treatment
AG Del Alba, JÁ Arranz, J Puente, MJ Méndez-Vidal, E Gallardo, ...
Critical reviews in oncology/hematology 113, 171-190, 2017
222017
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant …
M Casarrubios, M Provencio, E Nadal, A Insa, ...
Journal for immunotherapy of cancer 10 (9), 2022
192022
PD-(L) 1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: a pairwise meta-analysis
J García-González, J Ruiz-Bañobre, FJ Afonso-Afonso, ...
Journal of Clinical Medicine 9 (7), 2093, 2020
172020
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
J Casal Rubio, JL Firvida-Perez, M Lazaro-Quintela, FJ Barón-Duarte, ...
Cancer chemotherapy and pharmacology 73, 451-457, 2014
132014
Renal primary angiosarcoma
B Carnero López, I Fernández Pérez, JA Carrasco Alvarez, ...
Clinical and Translational Oncology 9, 806-810, 2007
132007
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer
U Anido Herranz, O Fernandez Calvo, FJ Afonso Afonso, ...
Expert Review of Anticancer Therapy 15 (3), 339-348, 2015
122015
Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor …
JL González-Larriba, M Lázaro-Quintela, M Cobo, M Dómine, M Majem, ...
Translational Lung Cancer Research 6 (Suppl 1), S21, 2017
112017
carcinoma tímico
J Castellanos Diez, M Lázaro Quintela, M Jorge Fernández, ...
Guía práctica de tumores poco frecuentes. Lázaro Quintela M, Jorge Fernández …, 2003
102003
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
N Lainez, J García-Donas, E Esteban, J Puente, MI Sáez, E Gallardo, ...
BMC cancer 16, 1-10, 2016
92016
Enzalutamide: A new prostate cancer targeted therapy against the androgen receptor
ML Quintela, LL Mateos, SV Estévez, OF Calvo, UA Herranz, FJA Afonso, ...
Cancer Treatment Reviews 41 (3), 247-253, 2015
82015
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
M Martin Jimenez, A Calvo Ferrandiz, J Aparicio Urtasun, ...
Clinical and Translational Oncology 19, 291-300, 2017
72017
Preferences for renal cell carcinoma pharmacological treatment: a discrete choice experiment in patients and oncologists
O Fernández, M Lázaro-Quintela, G Crespo, D Soto de Prado, Á Pinto, ...
Frontiers in Oncology 11, 773366, 2022
62022
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
U Anido-Herranz, N Fernández-Núñez, J Afonso-Afonso, ...
Clinical and Translational Oncology 21, 249-258, 2019
62019
Prostate cancer perspectives after chaarted: optimizing treatment sequence
SV Estévez, UA Herranz, OF Calvo, FJA Afonso, LS Couto, ML Quintela, ...
Critical Reviews in Oncology/Hematology 107, 119-127, 2016
62016
Disseminated classic Kaposi's sarcoma
I Fernández Pérez, L Vázquez Tuñas, M Lázaro Quintela, ...
Clinical and Translational Oncology 9, 255-257, 2007
62007
The system can't perform the operation now. Try again later.
Articles 1–20